Propel Bio Partners — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Inherent is an AI research lab, incorporated as a Public Benefit Corporation, developing general-purpose inventive AI systems and "AI Scientist" agents intended to accelerate research and power autonomous labs.
AI & Machine LearningDeep TechEnterprise Software
Co-investorsIndex VenturesRadical VenturesEx/AnteMacroscopic VenturesMetaplanetMythos Ventures Management, Llc
Inherent develops general-purpose AI agents designed to augment scientific research and discovery across disciplines.
AI & Machine LearningDeep Tech
Louis Kirsch(Founder)inTantum Collins(Founder)inEdward Hughes(Founder)Kaloyan Aleksiev(Founder)
Co-investorsMythos Ventures Management, LlcEx/AnteIndex VenturesMacroscopic VenturesMetaplanetRadical Ventures
Inherent Biosciences develops clinical diagnostic solutions using epigenetics and AI to address complex healthcare concerns.
AI & Machine LearningBiotechDigital HealthSalt Lake City, US
Andy Olson(Founder)inKristin Brogaard, PhD(Founder)in
Co-investorsMedMountain VenturesPortfoliaUtah Innovation FundAlliance of Angels
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.










